ResearcherJiangsu UniversityActive in the last 2 years
Zining Zhang
Matched on ORCID iD 0000-0002-7992-426X; OpenAlex author ID A5030460543. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- T‑Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplat… First author DOI 10.1021/acsptsci.6c00065↗
- Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy. First author DOI 10.1021/acsptsci.6c00148↗
- KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Co-author DOI 10.3389/fcell.2023.1147676↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hsiang‐i Tsai · 3 shared papers, 2023–2026 · strength 0.85
- Paper T‑Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 … DOI 10.1021/acsptsci.6c00065↗
- Paper Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy. DOI 10.1021/acsptsci.6c00148↗
- Paper KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. DOI 10.3389/fcell.2023.1147676↗
- Wenlong Chen · 1 shared paper, 2026 · strength 0.30
- Ke Zhou · 1 shared paper, 2026 · strength 0.29
- Guoquan Feng · 1 shared paper, 2026 · strength 0.29
- Xiang Liao · 1 shared paper, 2023 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.